V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) A 7 2 9 - A 7 3 1 A729

Copyright © 2013, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.

DISCLOSURE INFORMATION RESEARCH PRESENTATIONS FINANCIAL DISCLOSURE STATEMENTS The International Society for Pharmacoeconomics and Outcomes Research asked all abstract contributors to disclose financial support for their research. The following financial support was declared: Reference Code Financial Support

BU1 Bristol Myers Squibb, Buenos Aires, Argentina BU2 None BU3 UCB de Mexico S.A. de C.V., México, Mexico; Pfizer S.A. de C.V., México,

Mexico; Productos Roche S. A. de C.V, México, Mexico BU4 Janssen-Cilag Farmaceutica LTD.A, São Paulo, Brazil CA1 Global Health Research Initiative, Ottawa, Canada CA2 CNPq, Brasília, Brazil CA3 Instituto Nacional de Cancerología, Bogotá, Colombia CA4 None CV1 IL Diagnostic S.A de C.V, Mexico, Mexico CV2 Bristol-Myers Squibb, Buenos Aires, Argentina; Pfizer, Buenos Aires,

Argentina CV3 Novartis Pharmaceuticals AG, Basel, Switzerland CV4 Pfizer INC., New York, NY, USAFD1 Grunenthal, Latinoamérica, Distrito federal, Mexico FD2 None FD3 None HC1 None HC2 None HC3 PriceSpective, Blue Bell, PA, USAHC4 Pfizer S.A.S., Bogota, ColombiaHT1 None HT2 None HT3 None HT4 None IN1 Merck & Co., West Point, PA, USAIN2 None IN3 None IN4 None PCN1 None PCN2 None PCN3 None PCN4 Pfizer S.A. de C.V., México, Mexico; Productos Roche S. A. de C.V, México,

Mexico; AstraZeneca México, México, Mexico PCN5 Bristol-Myers Squibb Farmacêutica S/A, São Paulo, Brazil PCN6 Roche Brazil, São Paulo, BrazilPCN7 AstraZeneca, Mexico City, MexicoPCN8 Pfizer S.A. de C.V., México, Mexico; Productos Roche S. A. de C.V, México,

Mexico; AstraZeneca México, México, Mexico PCN10 None PCN11 F. Hoffmann-La Roche, Basel, Switzerland PCN12 IMS Health, Mexico City, Mexico; Janssen, Mexico City, MexicoPCN13 None PCN14 Janssen-Cilag Farmaceutica Ltd.a, Sao Paulo, Brazil PCN15 None PCN16 GlaxoSmithKline, Rio de Janeiro, Brazil PCN17 CNPq, Brasília, Brazil PCN18 Novartis Oncology, Mexico City, Mexico PCN19 Roche Colombia, Bogotá D.C, Colombia PCN20 Roche Colombia, Bogotá D.C, Colombia PCN21 Takeda Mexico SA de CV, Mexico City, Mexico PCN22 None PCN23 BOEHRINGER INGELHEIM, MEXICO, Mexico PCN24 None PCN25 None PCN26 ICON, Dublin, Ireland PCN27 Conselho Nacional de Pesquisa – CNPq , Brasília, Brazil; Fundação de

Amparo à Pesquisa do Estado de Minas Gerais - FAPEMIG, Belo Horizonte, Brazil; Ministério da Saúde/ Departamento de Ciência e Tecnologia, Brasília, Brazil; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES, Brasília, Brazil

PCN28 None PCN29 None PCN30 None PCV1 Bristol-Myers Squibb, Bogota, Colombia; Pfizer, Bogota, ColombiaPCV2 IMS Health, Mexico City, MexicoPCV3 Salud Investiga, Ministry of Health, Argentina, CABA, Argentina; Roche,

Pacheco, Argentina PCV4 None PCV5 COLCIENCIAS, Bogota DC, Colombia PCV6 Merck Sharp and Dohme Corp., Whitehouse Station, NJ, USAPCV7 Canadian Institute of Health Research (CIHR), Ottawa, ON, CanadaPCV8 Pfizer Inc., New York, NY, USAPCV9 None

Reference Code Financial Support

PCV10 NonePCV11 FONIS-CONICYT, Santiago, Chile; UNIVERSIDAD MAYOR, Santiago, ChilePCV12 NonePCV13 NonePCV14 NonePCV15 NonePCV16 NonePCV17 NonePCV18 NonePCV19 NonePCV20 IMS Health, Mexico City, Mexico PCV21 Medtronic, Minneapolis, MN, USA PCV22 NonePCV24 NonePCV25 Inversiones Ajoveco, Bogota, Colombia PCV27 Sanofi Mexico, Ciudad de Mexico, Mexico PCV28 Boehringer Ingelheim SA- Argentina, Munro, Argentina PCV29 Bristol-Myers Squibb, Bogota, Colombia; Pfizer, Bogota, ColombiaPCV30 NonePCV31 Novartis Pharma AG, Basel, Switzerland PCV32 Sanofi Mexico, Mexico, Mexico PCV33 NonePCV34 NonePCV35 Pharmaceutical Research and Manufacturers of America, Washington, DC,

USA PCV36 NonePCV37 NonePCV38 Universidad del Desarrollo, Santiago, Chile PCV39 NonePCV40 IMS Health, Mexico City, Mexico PDB1 Boehringer Ingelheim Colombia, Bogotá, Colombia PDB2 Boehringer-ingelheim Colombia, Bogota, Colombia PDB3 ABBVIE, Mexico City, Mexico PDB4 Sanofi-aventis de Colombia S.A., Bogotá, Colombia PDB5 Novo Nordisk A/S, Søborg, Denmark PDB6 Eli Lilly and Company, Indianapolis, IN, USA PDB7 Eli Lilly and Company, Indianapolis, IN, USA PDB8 NonePDB9 Abbvie, Mexico City, Mexico PDB10 NOVARTIS, Mexico City, Mexico PDB11 NonePDB12 Janssen Global Services, LLC, Raritan, NJ, USA PDB13 Eli Lilly Mexico, Mexico, Mexico PDB14 Medtronic, Bogota, Colombia PDB15 Novo Nordisk A/S, Søborg, Denmark PDB16 Novo Nordisk A/S, Søborg, Denmark PDB18 NonePDB19 Novo Nordisk, Martinez, Argentina PDB20 NonePDB21 Novartis Pharma AG, Basel, Switzerland PDB22 NonePDB23 NonePDB25 The Islamia University of Bahawalpur, Bahawalpur, PakistanPDB26 NonePGI1 NonePGI2 Janssen Pharmaceuticals, Inc., Raritan, NJ, USA PGI3 Inversiones Ajoveco, Bogota, Colombia PGI4 Thermo Fisher Scientific, Uppsala, Sweden PGI5 Janssen Pharmaceuticals, Inc., Raritan, NJ, USA PGI6 Janssen, Bogotá, Colombia PGI7 Janssen Cilag, Bogotá, Colombia PGI8 NonePGI9 NonePHP1 NonePHP2 Abbott, Basel, Switzerland PHP4 Ministério da Saúde, João Pessoa, Brazil PHP5 Pacific Rim, San Francisco, CA, USA PHP6 GDN, Washinton DC, WA, USA PHP7 ICON, LA, CA, USAPHP8 NonePHP9 NonePHP10 Ministry of Health, Buenos Aires, Argentina PHP11 NonePHP12 None

A730 V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) A 7 2 9 - A 7 3 1

Reference Code Financial Support

PHP14 ICON, LA, CA, USA PHP15 None PHP16 None PHP17 Comité para el desarrollo de la investigación CODI, Medellín, ColombiaPHP18 CNPq, Brasilia, Brazil PHP19 None PHP20 Hospital universitario austral, derqui, Argentina; Salud Investiga, Ministerio

de Salud, CABA, Argentina PHP22 Inversiones Ajoveco S.A., Bogota, Colombia PHP23 Ministério da Saúde, Brasília, Brazil PHP24 Covidien, Mansfield, MA, USA PHP26 None PHP28 Great Lakes University of Kisumu, Kisumu, Kenya PHP29 None PHP30 Great Lakes University of Kisumu, Kisumu, Kenya PHP31 ARP SURA, Medellin, ColombiaPHP32 None PHP34 None PHP35 None PHP36 None PHP37 None PHP38 Johnson & Johnson Medical, Buenos Aires, Argentina PHP39 None PHP40 None PHP41 None PHP42 IHS, London, PHP43 National Counsel of Technological and Scientific Development, Goiânia -

Goiás, Brazil PHP44 Ministry of Health, Santiago del Estero, Argentina; Department of Medicine

and Health Systems, Hospital Austral, Derqui, USA PHP45 None PHP46 Departamento Administrativo de Ciencia y Tecnología - Colciencias, CT:

399-2011, Code: 110154532178, Bogotá, Colombia PHP47 GlaxoSmithKline Slovakia, Bratislava, Slovak Republic PHP48 None PHP49 Double Helix Consulting, LondonPHP51 None PHP52 Universidad del Desarrollo, Santiago, Chile PHP53 Ministério da Saúde, Brasília, Brazil PHP54 Japan Society for the Promotion of Science, Tokyo, Japan PHP55 Salud Investiga, Ministry of Health Argentina, CABA, Argentina; Department

of Medicine and Health Systems, Hospital Austral, Derqui, Argentina PHP56 None PHP57 None PHP58 None PHP59 Instituto De Evaluación Tecnológica En Salud, Bogotá, Colombia; Banco

Interamericano De Desarrollo - BID, BOGOTÁ, Colombia PHP60 None PHP61 None PHP62 None PHP63 IMS Consulting Group, London PHP64 IMS Consulting Group, London PHP65 None PHP66 None PHP67 None PHP68 None PIH1 None PIH2 GSK, London, PIH3 LUMHS, Jamshoro, Pakistan PIH4 None PIH5 Bayer Colombia, Bogota, Colombia PIH6 None PIH7 None PIH8 None PIH9 None PIH10 Ministerio de Desarrollo Social, Santiago, Chile PIH11 Colciencias, Bogotá, ColombiaPIH12 None PIH13 helPharma, Medellin, ColombiaPIH14 Novartis Pharmaceuticals, East Hanover, NJ, USA PIH15 None PIH17 Central University of Venezuela, Caracas, Venezuela PIH18 None PIH19 Consejo Nacional de Ciencia y Tecnología (CONACYT), Ciudad de México,

México PIN1 None PIN2 None PIN3 Merck & Co., West Point, PA, USAPIN4 National Institute of Pharmaceutical Education and Research (NIPER), SAS

Nagar, India PIN5 None PIN6 Pfizer, Buenos Aires, ArgentinaPIN7 ProVac - PAHO, Washington DC, WA, USA

Reference Code Financial Support

PIN8 Janssen Cilag, Bogotá, Colombia PIN9 COLCIENCIAS, Bogotá, Colombia PIN10 Pfizer S.A.S., Bogota, Colombia PIN11 Merck & Co., Whitehouse Station, NJ, USA PIN12 Merck & Co., West Point, PA, USA PIN13 IL diagnostic S.A de C.V, Mexico, Mexico PIN14 Novartis Argentina, Buenos Aires, Argentina PIN15 COLCIENCIAS, Bogotá, Colombia PIN16 Janssen, Panama, Panama PIN17 Ministry of Health, Astana, Kazakhstan PIN18 NonePIN19 NonePIN20 NonePMH1 NonePMH2 NonePMH3 Eli Lilly and Company, Windlesham, PMH4 NonePMH5 NonePMH6 Fapesp, SAO PAULO, Brazil; Ministry of Health/Decit, Brasilia, BrazilPMH7 BraInc.om, Bilbao, SpainPMH8 Janssen Cilag, Bogotá, Colombia PMH9 Janssen, Panama, Panama PMH10 Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brasília,

Brazil PMH11 Department of Mental Health, Bangkok, Thailand PMH12 NonePMH14 Fapesp, São Paulo, BrazilPMS1 Conselho Nacional de Desenvolvimento Científico e Tecnológico - CNPq,

Brasília, Brazil PMS2 Roche Brazil, São Paulo, Brazil PMS3 NonePMS4 Roche Brazil, São Paulo, Brazil PMS5 Roche Brazil, São Paulo, Brazil PMS6 Pfizer SAS, Bogota, Colombia PMS7 Pfizer SAS, Bogotá DC, Colombia PMS9 CNPq, Brasília, Brazil; Fapemig, Belo Horizonte, Brazil PMS10 Fapemig, Belo Horizonte, Brazil; CNPq, Brasília, Brazil PMS11 Novartis Pharmaceutical Corporation, East Hanover, NJ, USAPMS12 Novartis Pharmaceutical Corporation, East Hanover, NJ, USAPMS13 Pfizer CIA.LTD.A, Quito, Ecuador PMS14 NonePMS15 Iroko Pharmaceuticals, Philadelphia, PA, USA PMS16 Aspid Pharma, Mexico, DF, Mexico PMS17 Pfizer, Santiago, ChilePMS18 Pfizer S.A.S., Bogota, Colombia PMS19 Janssen Research & Development, LLC, Spring House, PA, USAPMS20 CNPq, Brasília, Brazil; FAPEMIG, Belo Horizonte, BrazilPMS21 Pfizer S.A.S., Bogota, Colombia PMS22 NonePMS23 NonePMS24 Pfizer S.A. de C.V., México, Mexico; UCB de México S.A. de C.V., México,

Mexico; Productos Roche S. A. de C.V, México, Mexico PMS25 NonePND1 Teva Neuroscience, Kansas City, MO, USA PND2 NonePND3 NonePND4 NonePND5 NonePND6 Novartis Biociências S.A., São Paulo, Brazil PND7 NOvartis, Buenos Aires, Argentina PND8 NonePND9 Pfizer S.A.S., Bogota, Colombia PND10 Pfizer S.A.S., Bogota, Colombia PND11 NonePND12 NonePND13 Novartis Biociências S.A., São Paulo, Brazil PND14 Novartis Pharma AG, Basel, Switzerland PND15 Novartis Biociências S.A., São Paulo, Brazil PND16 Novartis Biociências S.A., São Paulo, Brazil PND17 NonePRM1 NonePRM3 NonePRM4 NonePRM5 NonePRM6 NonePRM7 Novartis de Colombia S.A., Bogotá D.C., Colombia PRM8 ORIZON, Barueri, BrazilPRM9 NonePRM10 Merck & Co, New Jersey, NJ, USA PRM11 Pfizer S.A.S., Bogota, Colombia PRM12 NonePRM13 NonePRM14 None

V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) A 7 2 9 - A 7 3 1 A731

Reference Code Financial Support

PRM15 None PRM16 None PRS2 MSD, White House Station, NJ, USA PRS3 Qatar University, Doha, Qatar PRS4 None PRS5 GlaxoSmithKline, Uxbridge, PRS6 IDRC, Ottawa, Canada PRS7 CAPES-Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

(Convênio DINTER UFG/UEMA), Brasília, Brazil PRS8 Instituto de Avaliação de Tecnologias em Saúde/Conselho Nacional de

Desenvolvimento Científico e Tecnológico-CNPq, Goiânia - Goiás, Brazil

PRS11 None PRS12 None PRS13 None PRS14 Merck & Co., Inc., West Point, PA, USA PRS15 None PR1 None PR2 Becton Dickinson de Mexico S.A. de C.V., Mexico, Mexico PR3 Pfizer SAS, Bogotá DC, ColombiaPR4 None PSS1 Ministerio de Salud, Santiago, Chile PSS2 Janssen Cilag, Bogotá, ColombiaPSS3 None PSS4 None PSS5 Ministerio de Salud, Chile, Santiago, Chile PSS6 Bayer Colombia, Bogota, Colombia PSS7 Bayer Alemania, Bogotá, Colombia PSY1 None PSY2 None PSY3 Baxter Healthcare Corporation, Westlake Village, CA, USA PSY4 None PSY5 Pfizer S.A. de C.V., Ciudad de México, Mexico PSY6 None PSY7 Audifarma, Bogota, Colombia

Reference Code Financial Support

PSY8 Programa Pesquisa para Sistema Único de Saúde (PPSUS), Curitiba, Brazil; Ministério da Educação/Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (MEC/CAPES), Curitiba, Brazil

PSY9 Janssen de México, Mexico, Mexico PSY10 NonePSY11 Bayer, Bogota, ColombiaPSY12 Beijing Novartis Pharma Co., Ltd.., Beijing, China PSY13 NonePSY14 NonePSY15 Novartis Pharmaceutical Corporation, East Hanover, NJ, USAPSY16 Double helix Consulting, London, PSY18 NonePUK1 RTS Baxter, Bogota, Colombia PUK2 NOVARTIS, Mexico City, Mexico PUK3 Bristol-Myers Squibb Colombia, Bogota, Colombia PUK4 Pfizer, Bogotá, ColombiaPUK5 Abbott Laboratórios do Brasil Ltd.a, São Paulo, Brazil PUK6 NonePUK8 Baxter, Bogotá, Colombia PUK9 Colciencis, Bogotá, Colombia PUK10 AMGEN, Brazil, BrazilPUK11 Sanofi-aventis de Colombia S.A., Bogotá, Colombia PUK12 NOVARTIS, Mexico City, Mexico PUK13 Pfizer, Bogota, ColombiaPUK14 NonePUK15 NoneRF1 NoneRF2 Grupo de Investigación en Economía de la Salud, Universidad de

Cartagena, Cartagena, Colombia RF3 NoneRF4 Roche Diagnostics, Sao Paulo, Brazil; Roche Molecular Diagnostics,

Pleasanton, CA, USA TR1 NoneTR2 NoneTR3 Baxter Healthcare Corporation, Westlake Village, CA, USATR4 None